Research and Markets: Cancer Stem Cell Trends & Designs of Novel Drugs Featuring Major Players Boston Biomedical, Macrogenics & Verastem

Business Wire


Research and Markets ( has announced the addition of the "Cancer Stem Cell Trends" report to their offering.

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal and driving tumorigenesis. In the previous research studies, rare CSCSs have been isolated from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might cause metastasis and relapse by producing new tumors.

In addition, the report highlights the exponential rise in research on Cancer Stem Cells (CSCs), and the design of novel drugs to treat CSCs. Major players in the field include Boston Biomedical Inc., Macrogenics, and Verastem, Inc.

Key Topics Covered:


  • Prelude
  • CSC Hypothesis
  • An Overview
  • Impact on Pharmacology Research and Modern Molecular Physiology
  • Limitations and Inconsistencies
  • Origin of CSCs Remains Elusive
  • CSC In Vitro Models
  • Cells from Tumor Lines
  • Genetic Manipulation of Cell Lines
  • Sorted Tumor Cells Selection
  • Properties of CSCs
  • Identification and Characterization of CSCs
  • Elimination of CSCs - The Key in Preventing Tumor Reappearance


  • Research on Cancer Stem Cell Accelerates
  • Existence of CSCs - A Topic of Debate
  • Hype Surrounding CSC Research Fails to Fetch End Results
  • Mathematical Models
  • Cellular Pathways
  • CSCs and the Wnt Pathway
  • Focal Adhesion Kinase (FAK)
  • Future of CSC Research


  • Cancer Stem Cells and Circulating Tumor Cells Market


  • Boston Biomedical, Inc. (USA)
  • Macrogenics (USA)
  • Verastem, Inc. (USA)


  • Bionomics Acquires Eclipse Therapeutics
  • Dainippon Sumitomo Pharma Acquires Boston Biomedical
  • Queensland University Scientists to Study Ovarian CSCs
  • Sanford-Burnham Researchers Study Isolated Ovarian CSCs
  • Harvard Medical School Researchers Suspect Radiotherapy and Chemotherapy in Development of CSCs
  • Mount Sinai School of Medicine Leads Research on CSCs to Develop New Therapies
  • University of Texas Scientists Research to Arrest Cancer Re- growth
  • McMaster's Stem Cell and Cancer Research Institute Scientists Discover Thioridazine's Potential to Kill CSCs
  • Ohio State University College of Medicine Proposes Cancer Stem Cells (CSCs) Theory
  • Research Collaboration Identifies Potential of Gamma-Tocotrienol
  • Research on Maintenance Mechanism by Cancers
  • Verastem to Develop Drugs Targeting Cancer Stem Cells
  • University of Michigan Researchers Study the Role of Cancer Stem Cells in Ovarian Cancer
  • Hong Kong Researchers Find CSCs with CD24 Surface Protein Aggravate Liver Cancer
  • CRUK to Research on Cancer-Combating Drugs
  • University of Michigan Researchers Use Experimental Drugs to Inhibit Breast Cancer
  • University of Pittsburgh Researchers Discover Prevention of Isolated CSCs from Differentiating


For more information visit

View Comments (0)